Propofol

Generic Name
Propofol
Brand Names
Diprivan
Drug Type
Small Molecule
Chemical Formula
C12H18O
CAS Number
2078-54-8
Unique Ingredient Identifier
YI7VU623SF
Background

Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.

Indication

Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.

Associated Conditions
-
Associated Therapies
Induction of anesthesia therapy, Maintenance of anesthesia therapy, Monitored anesthesia care sedation, Sedative therapy

Influence of Anesthesia on Mechanical Efficiency of Left Ventricle in Patients Undergoing Open Heart Surgery

First Posted Date
2011-07-19
Last Posted Date
2018-04-24
Lead Sponsor
Sheba Medical Center
Target Recruit Count
28
Registration Number
NCT01397331
Locations
🇮🇱

Department of Anesthesia and Intensive Care, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery

Phase 4
Completed
Conditions
Interventions
First Posted Date
2011-06-29
Last Posted Date
2013-04-12
Lead Sponsor
Yonsei University
Target Recruit Count
112
Registration Number
NCT01384643
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Reducing Delirium After Cardiac Surgery: A Multifaceted Approach Of Perioperative Care

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-06-22
Last Posted Date
2015-04-21
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
185
Registration Number
NCT01378741
Locations
🇨🇦

University Health Network, Toronto, Ontario, Canada

The Energy Dose Study

First Posted Date
2011-06-08
Last Posted Date
2022-06-10
Lead Sponsor
Emory University
Target Recruit Count
12
Registration Number
NCT01369147
Locations
🇺🇸

Emory University Hospital, Atlanta, Georgia, United States

Trial Comparing Sedation for Endoscopy With Propofol Versus Midazolam in Cirrhotics

First Posted Date
2011-05-19
Last Posted Date
2011-05-19
Lead Sponsor
Govind Ballabh Pant Hospital
Target Recruit Count
120
Registration Number
NCT01356121
Locations
🇮🇳

Prof Barjesh Chander Sharma, New Delhi, Delhi, India

Dexmedetomidine and Propofol in Children With History of Obstructive Sleep Apnea

First Posted Date
2011-04-29
Last Posted Date
2018-08-08
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Target Recruit Count
60
Registration Number
NCT01344759
Locations
🇺🇸

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Postoperative Analgesia in Children After Propofol Anesthesia

Phase 1
Conditions
Interventions
First Posted Date
2011-04-27
Last Posted Date
2011-04-27
Lead Sponsor
University Clinical Centre of Kosova
Target Recruit Count
100
Registration Number
NCT01342835
Locations
🇷🇸

University Clinical Center of Kosovo, Pristina, Kosovo, Serbia

Providing "Good Sleep" for ICU Sedation

First Posted Date
2011-04-27
Last Posted Date
2018-12-19
Lead Sponsor
University of California, San Francisco
Target Recruit Count
3
Registration Number
NCT01342328
Locations
🇺🇸

University of California San Francisco, San Francisco, California, United States

Oxidative Stress in Robot-assisted Laparoscopic Radical Prostatectomy

Not Applicable
Conditions
Interventions
First Posted Date
2011-04-13
Last Posted Date
2011-04-13
Lead Sponsor
Chang Gung Memorial Hospital
Target Recruit Count
40
Registration Number
NCT01334424
Locations
🇨🇳

Dept. of Anesthesiology, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan

Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures.

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2011-03-30
Last Posted Date
2014-03-26
Lead Sponsor
Cristália Produtos Químicos Farmacêuticos Ltda.
Registration Number
NCT01326078
© Copyright 2024. All Rights Reserved by MedPath